iThera in the news

iThera Medical announced as a ‘Top Presenting Company’ by Tech Tour

December 29, 2022
For nearly 20 years, Tech Tour has built a community of innovative professionals focused on emerging technologies across Europe. Recently, Tech Tour selected iThera Medical as one of the top companies in 2022.

For nearly 20 years, Tech Tour has built a community of innovative professionals focused on emerging technologies across Europe. Recently, Tech Tour selected iThera Medical as one of the top companies in 2022. The selection is based on several evaluation criteria, including management experience, product technology, market potential, go-to-market strategy, competitive position, and business model credibility. Receiving this award, honors iThera’s breakthrough imaging technology and position as a market leader for optoacoustic imaging.

 

About Tech Tour

Tech Tour was founded in 1998 to fulfill the need for a trustworthy and transparent environment, in which experts could share best practices and transfer knowledge across a network to identify and support the best emergent technologies in Europe. It has since then become one of the largest investor-oriented communities in Europe connecting entrepreneurs, investors, and corporate partners from across the world. Over 2,000 high-tech companies apply and 750 investors take part in 25 tech events held each year.

About

Since its incorporation in 2010, iThera Medical develops and markets optoacoustic imaging systems for preclinical and clinical research. More recently, the company has started translating its technology for routine diagnostic clinical use across various types of diseases, including cancer, inflammatory, fibrotic, and cardiovascular diseases. Optoacoustic imaging utilizes the photoacoustic effect – the conversion of light energy into acoustic signals – to visualize and quantify optical contrast in deep tissue, at high spatial and temporal resolution.
Since its incorporation in 2010, iThera Medical develops and markets optoacoustic imaging systems for preclinical and clinical research. More recently, the company has started translating its technology for routine diagnostic clinical use across various types of diseases, including cancer, inflammatory, fibrotic, and cardiovascular diseases. Optoacoustic imaging utilizes the photoacoustic effect – the conversion of light energy into acoustic signals – to visualize and quantify optical contrast in deep tissue, at high spatial and temporal resolution.

For further information, please contact:
Christian Wiest
Phone: +49 (0) 89 700 7449-21
Email: ch*************@it************.com